Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brachytherapy | 60 | 2022 | 1221 | 6.400 |
Why?
|
Radiation Oncology | 7 | 2022 | 572 | 1.400 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 14 | 2021 | 1673 | 1.190 |
Why?
|
Radiotherapy Dosage | 31 | 2022 | 2916 | 1.110 |
Why?
|
Mycosis Fungoides | 4 | 2023 | 169 | 0.850 |
Why?
|
Carcinoma, Squamous Cell | 8 | 2020 | 4050 | 0.780 |
Why?
|
Skin Neoplasms | 14 | 2023 | 5860 | 0.740 |
Why?
|
Radiotherapy | 4 | 2019 | 1497 | 0.710 |
Why?
|
Organs at Risk | 4 | 2019 | 367 | 0.710 |
Why?
|
Iodine Radioisotopes | 6 | 2014 | 1030 | 0.690 |
Why?
|
Penile Neoplasms | 1 | 2020 | 158 | 0.610 |
Why?
|
Neoplasm Recurrence, Local | 16 | 2022 | 9407 | 0.560 |
Why?
|
Carcinoma, Basal Cell | 2 | 2019 | 565 | 0.550 |
Why?
|
Radiation Injuries | 7 | 2021 | 1195 | 0.540 |
Why?
|
Meningioma | 3 | 2022 | 1221 | 0.530 |
Why?
|
Salvage Therapy | 3 | 2022 | 1274 | 0.520 |
Why?
|
Meningeal Neoplasms | 3 | 2022 | 1255 | 0.520 |
Why?
|
Coronary Restenosis | 2 | 2017 | 396 | 0.500 |
Why?
|
Graft Occlusion, Vascular | 2 | 2017 | 538 | 0.480 |
Why?
|
Mediastinal Neoplasms | 2 | 2008 | 403 | 0.470 |
Why?
|
Prostatic Neoplasms | 13 | 2019 | 11094 | 0.460 |
Why?
|
Neurosurgery | 1 | 2019 | 682 | 0.420 |
Why?
|
Radiometry | 4 | 2012 | 814 | 0.410 |
Why?
|
Facial Neoplasms | 1 | 2013 | 126 | 0.390 |
Why?
|
Drug-Eluting Stents | 1 | 2017 | 681 | 0.360 |
Why?
|
Carcinoma, Merkel Cell | 4 | 2022 | 329 | 0.360 |
Why?
|
Dermatology | 1 | 2020 | 905 | 0.330 |
Why?
|
Liver Neoplasms | 4 | 2021 | 4356 | 0.320 |
Why?
|
Carcinoid Tumor | 2 | 2009 | 225 | 0.310 |
Why?
|
Quinuclidines | 1 | 2008 | 27 | 0.310 |
Why?
|
Serotonin Antagonists | 1 | 2008 | 146 | 0.300 |
Why?
|
Sarcoma | 6 | 2014 | 1802 | 0.300 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3692 | 0.290 |
Why?
|
Radiotherapy, Adjuvant | 7 | 2019 | 1788 | 0.290 |
Why?
|
Hepatic Artery | 1 | 2008 | 233 | 0.280 |
Why?
|
Isoquinolines | 1 | 2008 | 349 | 0.270 |
Why?
|
Thoracic Neoplasms | 1 | 2009 | 269 | 0.270 |
Why?
|
Radiotherapy, Conformal | 1 | 2010 | 545 | 0.270 |
Why?
|
Breast Neoplasms | 8 | 2020 | 21162 | 0.250 |
Why?
|
Smallpox | 1 | 2005 | 43 | 0.250 |
Why?
|
Nausea | 1 | 2008 | 681 | 0.250 |
Why?
|
Smallpox Vaccine | 1 | 2005 | 77 | 0.240 |
Why?
|
Vomiting | 1 | 2008 | 652 | 0.240 |
Why?
|
Health Care Surveys | 1 | 2012 | 2425 | 0.240 |
Why?
|
Prostate-Specific Antigen | 2 | 2017 | 2463 | 0.240 |
Why?
|
Societies, Medical | 6 | 2022 | 3957 | 0.240 |
Why?
|
Embolization, Therapeutic | 2 | 2019 | 1403 | 0.240 |
Why?
|
Dose-Response Relationship, Radiation | 5 | 2017 | 877 | 0.230 |
Why?
|
Head and Neck Neoplasms | 2 | 2011 | 2930 | 0.220 |
Why?
|
Breast | 2 | 2008 | 1972 | 0.200 |
Why?
|
Rectum | 5 | 2017 | 897 | 0.200 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2171 | 0.190 |
Why?
|
Humans | 81 | 2023 | 766812 | 0.190 |
Why?
|
Aged | 36 | 2020 | 171344 | 0.190 |
Why?
|
Lymphoma, Primary Cutaneous Anaplastic Large Cell | 1 | 2021 | 8 | 0.190 |
Why?
|
Treatment Outcome | 23 | 2020 | 65286 | 0.190 |
Why?
|
Survival Rate | 7 | 2019 | 12826 | 0.180 |
Why?
|
Paget Disease, Extramammary | 1 | 2021 | 50 | 0.180 |
Why?
|
Genital Neoplasms, Male | 1 | 2021 | 68 | 0.180 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2019 | 210 | 0.170 |
Why?
|
Combined Modality Therapy | 7 | 2019 | 8540 | 0.170 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2021 | 168 | 0.160 |
Why?
|
Early Detection of Cancer | 1 | 2013 | 3235 | 0.160 |
Why?
|
Internet | 2 | 2020 | 3113 | 0.160 |
Why?
|
Aged, 80 and over | 17 | 2020 | 59548 | 0.160 |
Why?
|
Cicatrix | 1 | 2005 | 798 | 0.160 |
Why?
|
Androgen Antagonists | 2 | 2017 | 1411 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 8 | 2021 | 20710 | 0.150 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2018 | 70 | 0.150 |
Why?
|
Mammography | 2 | 2010 | 2429 | 0.150 |
Why?
|
Middle Aged | 34 | 2020 | 223267 | 0.150 |
Why?
|
Patient Selection | 3 | 2019 | 4252 | 0.150 |
Why?
|
Consumer Health Information | 1 | 2020 | 215 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 11876 | 0.150 |
Why?
|
Nuclear Medicine | 1 | 2021 | 262 | 0.140 |
Why?
|
Male | 41 | 2021 | 364154 | 0.140 |
Why?
|
Carcinoma | 1 | 2009 | 2325 | 0.140 |
Why?
|
SEER Program | 2 | 2020 | 1444 | 0.140 |
Why?
|
Acrodermatitis | 1 | 2017 | 15 | 0.140 |
Why?
|
Adenocarcinoma | 4 | 2016 | 6359 | 0.140 |
Why?
|
Skin | 4 | 2020 | 4499 | 0.140 |
Why?
|
Neoplasms | 3 | 2022 | 22350 | 0.130 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2016 | 66 | 0.130 |
Why?
|
Soft Tissue Neoplasms | 2 | 2012 | 1163 | 0.130 |
Why?
|
Foot Dermatoses | 1 | 2016 | 46 | 0.130 |
Why?
|
Hand Dermatoses | 1 | 2016 | 61 | 0.130 |
Why?
|
Radiotherapy, Computer-Assisted | 4 | 2010 | 90 | 0.130 |
Why?
|
Yttrium Radioisotopes | 3 | 2021 | 116 | 0.130 |
Why?
|
Female | 36 | 2022 | 396532 | 0.120 |
Why?
|
Survival Analysis | 5 | 2017 | 10101 | 0.120 |
Why?
|
Postoperative Period | 1 | 2020 | 1824 | 0.120 |
Why?
|
Comprehension | 1 | 2020 | 638 | 0.120 |
Why?
|
Software Validation | 1 | 2014 | 59 | 0.120 |
Why?
|
Databases, Factual | 5 | 2019 | 8065 | 0.120 |
Why?
|
Popliteal Artery | 1 | 2016 | 313 | 0.120 |
Why?
|
Mammaplasty | 1 | 2005 | 1268 | 0.120 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2017 | 2039 | 0.120 |
Why?
|
Retrospective Studies | 17 | 2022 | 81657 | 0.120 |
Why?
|
Intermittent Claudication | 1 | 2016 | 305 | 0.110 |
Why?
|
Consensus | 2 | 2015 | 3208 | 0.110 |
Why?
|
Genital Neoplasms, Female | 2 | 2009 | 534 | 0.110 |
Why?
|
United States | 10 | 2022 | 72945 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2009 | 5389 | 0.110 |
Why?
|
Extremities | 2 | 2017 | 869 | 0.100 |
Why?
|
Hidradenitis Suppurativa | 1 | 2016 | 176 | 0.100 |
Why?
|
Fluorouracil | 2 | 2011 | 1652 | 0.100 |
Why?
|
Angioplasty, Balloon | 1 | 2016 | 592 | 0.100 |
Why?
|
Femoral Artery | 1 | 2016 | 827 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39312 | 0.100 |
Why?
|
Models, Biological | 1 | 2008 | 9464 | 0.100 |
Why?
|
Cisplatin | 2 | 2011 | 1656 | 0.100 |
Why?
|
Erythema | 1 | 2013 | 261 | 0.090 |
Why?
|
Iridium Radioisotopes | 3 | 2009 | 26 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1814 | 0.090 |
Why?
|
Skin Diseases | 1 | 2020 | 1084 | 0.090 |
Why?
|
Lower Extremity | 2 | 2016 | 1217 | 0.090 |
Why?
|
Film Dosimetry | 2 | 2017 | 30 | 0.090 |
Why?
|
Time Factors | 6 | 2017 | 40149 | 0.090 |
Why?
|
Prosthesis Design | 1 | 2017 | 2120 | 0.090 |
Why?
|
Radiobiology | 1 | 2010 | 90 | 0.080 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2013 | 335 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 5 | 2019 | 6514 | 0.080 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2013 | 594 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1521 | 0.080 |
Why?
|
Feasibility Studies | 4 | 2021 | 5306 | 0.080 |
Why?
|
Radiation Protection | 1 | 2012 | 425 | 0.080 |
Why?
|
Mastectomy | 2 | 2008 | 1861 | 0.080 |
Why?
|
Ischemia | 1 | 2016 | 1905 | 0.070 |
Why?
|
Mediastinum | 1 | 2009 | 272 | 0.070 |
Why?
|
Carboplatin | 1 | 2011 | 790 | 0.070 |
Why?
|
Psoriasis | 1 | 2016 | 925 | 0.070 |
Why?
|
Taxoids | 1 | 2011 | 665 | 0.070 |
Why?
|
Strontium Radioisotopes | 2 | 2004 | 18 | 0.070 |
Why?
|
Technology, Radiologic | 1 | 2007 | 158 | 0.070 |
Why?
|
Prospective Studies | 9 | 2021 | 54872 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2329 | 0.070 |
Why?
|
Organizational Objectives | 1 | 2008 | 426 | 0.070 |
Why?
|
Adult | 18 | 2019 | 223305 | 0.070 |
Why?
|
Polyethylene Glycols | 1 | 2012 | 1189 | 0.070 |
Why?
|
Rectal Diseases | 1 | 2007 | 141 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2017 | 3552 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6214 | 0.060 |
Why?
|
Prevotella melaninogenica | 1 | 2005 | 13 | 0.060 |
Why?
|
Streptococcus mitis | 1 | 2005 | 7 | 0.060 |
Why?
|
Capnocytophaga | 1 | 2005 | 26 | 0.060 |
Why?
|
Vaginal Neoplasms | 1 | 2006 | 105 | 0.060 |
Why?
|
Coronary Vessels | 1 | 2017 | 3115 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3667 | 0.060 |
Why?
|
Medical Oncology | 1 | 2017 | 2340 | 0.060 |
Why?
|
Hepatectomy | 1 | 2009 | 589 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2017 | 4525 | 0.060 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1304 | 0.060 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 426 | 0.060 |
Why?
|
History, 18th Century | 1 | 2005 | 206 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2002 | 10384 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3193 | 0.060 |
Why?
|
Organizational Culture | 1 | 2008 | 513 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8890 | 0.060 |
Why?
|
Neoplasm, Residual | 1 | 2009 | 1012 | 0.060 |
Why?
|
Neoplasm Staging | 5 | 2019 | 11218 | 0.060 |
Why?
|
Tomography, Optical Coherence | 1 | 2017 | 2954 | 0.060 |
Why?
|
Tongue Neoplasms | 1 | 2005 | 185 | 0.050 |
Why?
|
Palliative Care | 2 | 2015 | 3640 | 0.050 |
Why?
|
History, 19th Century | 1 | 2005 | 714 | 0.050 |
Why?
|
Radiation Dosage | 3 | 2017 | 1958 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 7430 | 0.050 |
Why?
|
Therapy, Computer-Assisted | 1 | 2005 | 265 | 0.050 |
Why?
|
Mass Media | 1 | 2005 | 303 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4892 | 0.050 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1804 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15912 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
Leucovorin | 1 | 2004 | 644 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2233 | 0.050 |
Why?
|
Colon, Sigmoid | 2 | 2017 | 124 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4591 | 0.050 |
Why?
|
Stomach Neoplasms | 1 | 2012 | 1480 | 0.050 |
Why?
|
Risk Factors | 5 | 2019 | 74889 | 0.050 |
Why?
|
Public Opinion | 1 | 2005 | 484 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2008 | 1408 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2008 | 1097 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2014 | 15831 | 0.050 |
Why?
|
Ultrasonography | 1 | 2014 | 5990 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2014 | 20146 | 0.040 |
Why?
|
Saliva | 1 | 2005 | 852 | 0.040 |
Why?
|
Propensity Score | 2 | 2019 | 1972 | 0.040 |
Why?
|
Phototherapy | 1 | 2023 | 368 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2007 | 1126 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2002 | 348 | 0.040 |
Why?
|
Mouth Neoplasms | 1 | 2005 | 597 | 0.040 |
Why?
|
Therapeutics | 1 | 2020 | 113 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6853 | 0.040 |
Why?
|
Incidence | 2 | 2021 | 21527 | 0.040 |
Why?
|
Drug Eruptions | 1 | 2002 | 335 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 2 | 2019 | 354 | 0.040 |
Why?
|
Suicide, Attempted | 1 | 2008 | 1413 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14653 | 0.040 |
Why?
|
Tumor Burden | 2 | 2016 | 1902 | 0.040 |
Why?
|
Adolescent | 7 | 2019 | 88902 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 36570 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2015 | 13489 | 0.040 |
Why?
|
Prostate | 2 | 2017 | 1760 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2008 | 8045 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2002 | 886 | 0.040 |
Why?
|
History, 20th Century | 1 | 2005 | 2764 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6575 | 0.040 |
Why?
|
Automation | 1 | 2020 | 586 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2008 | 3468 | 0.030 |
Why?
|
Endometrial Neoplasms | 1 | 2006 | 1381 | 0.030 |
Why?
|
Catheters | 1 | 2020 | 428 | 0.030 |
Why?
|
Medical Records | 1 | 2002 | 1408 | 0.030 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2013 | 798 | 0.030 |
Why?
|
Urinary Bladder | 2 | 2017 | 1155 | 0.030 |
Why?
|
Skin Transplantation | 2 | 2012 | 1097 | 0.030 |
Why?
|
Young Adult | 5 | 2019 | 59939 | 0.030 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2016 | 198 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2014 | 3610 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2002 | 1409 | 0.030 |
Why?
|
Heart | 1 | 2008 | 4425 | 0.030 |
Why?
|
Prognosis | 4 | 2018 | 29959 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 598 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13644 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2020 | 865 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1754 | 0.030 |
Why?
|
Computer Simulation | 1 | 2008 | 6258 | 0.030 |
Why?
|
Clone Cells | 1 | 2018 | 1670 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12536 | 0.030 |
Why?
|
Bacteria | 1 | 2005 | 2212 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2021 | 822 | 0.030 |
Why?
|
Diagnosis-Related Groups | 1 | 2015 | 445 | 0.030 |
Why?
|
Vascular Patency | 1 | 2016 | 915 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2016 | 1104 | 0.030 |
Why?
|
Electroencephalography | 1 | 2008 | 6282 | 0.020 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2012 | 73 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1251 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3681 | 0.020 |
Why?
|
Swine | 1 | 2021 | 5985 | 0.020 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2012 | 140 | 0.020 |
Why?
|
Angiography | 1 | 2016 | 1595 | 0.020 |
Why?
|
Neoadjuvant Therapy | 2 | 2013 | 2902 | 0.020 |
Why?
|
Sampling Studies | 1 | 2012 | 614 | 0.020 |
Why?
|
Risk Assessment | 2 | 2013 | 24299 | 0.020 |
Why?
|
Water | 1 | 2017 | 1416 | 0.020 |
Why?
|
Language | 1 | 2020 | 1550 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7585 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2014 | 492 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2008 | 4810 | 0.020 |
Why?
|
Lung | 1 | 2008 | 10068 | 0.020 |
Why?
|
Safety | 1 | 2014 | 1157 | 0.020 |
Why?
|
Cesium Radioisotopes | 1 | 2009 | 38 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4652 | 0.020 |
Why?
|
Cancer Care Facilities | 1 | 2012 | 428 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1989 | 2571 | 0.020 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1989 | 111 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2474 | 0.020 |
Why?
|
Mastectomy, Segmental | 1 | 2013 | 974 | 0.020 |
Why?
|
Software | 1 | 2002 | 4464 | 0.020 |
Why?
|
Upper Extremity | 1 | 2012 | 684 | 0.020 |
Why?
|
Algorithms | 1 | 2007 | 14073 | 0.020 |
Why?
|
Palladium | 1 | 2007 | 67 | 0.020 |
Why?
|
Hydrogels | 1 | 2012 | 729 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2012 | 1319 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10580 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2413 | 0.020 |
Why?
|
Leg | 1 | 2010 | 1087 | 0.020 |
Why?
|
Radioisotopes | 1 | 2007 | 509 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12064 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6779 | 0.010 |
Why?
|
Genes | 1 | 1988 | 1824 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8507 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2012 | 1680 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9346 | 0.010 |
Why?
|
Critical Illness | 1 | 2016 | 2750 | 0.010 |
Why?
|
Preoperative Care | 1 | 2012 | 2253 | 0.010 |
Why?
|
Beta Particles | 1 | 2003 | 52 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5873 | 0.010 |
Why?
|
Smoking | 2 | 2013 | 9077 | 0.010 |
Why?
|
Equipment Design | 1 | 2010 | 3488 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8623 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12985 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2800 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 1988 | 0.010 |
Why?
|
Functional Laterality | 1 | 2008 | 2244 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7841 | 0.010 |
Why?
|
Brain | 1 | 2008 | 27158 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8734 | 0.010 |
Why?
|
ROC Curve | 1 | 2008 | 3621 | 0.010 |
Why?
|
Reference Values | 1 | 2005 | 4914 | 0.010 |
Why?
|
Coronary Stenosis | 1 | 2004 | 804 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7073 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2005 | 1390 | 0.010 |
Why?
|
Liver | 1 | 2012 | 7571 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6548 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10745 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2003 | 1161 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2004 | 2189 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4853 | 0.010 |
Why?
|
Pilot Projects | 1 | 2006 | 8728 | 0.010 |
Why?
|
Radiography | 1 | 2004 | 6968 | 0.010 |
Why?
|
Child | 1 | 2021 | 80670 | 0.010 |
Why?
|
Piperazines | 1 | 2003 | 2547 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 13476 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1988 | 10263 | 0.010 |
Why?
|
Cohort Studies | 1 | 2013 | 41706 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168939 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1989 | 774 | 0.000 |
Why?
|
Restriction Mapping | 1 | 1989 | 848 | 0.000 |
Why?
|
Base Sequence | 2 | 1989 | 12415 | 0.000 |
Why?
|
Amino Acid Sequence | 2 | 1989 | 13411 | 0.000 |
Why?
|
Molecular Sequence Data | 2 | 1989 | 17609 | 0.000 |
Why?
|
Cell Line | 2 | 1989 | 15564 | 0.000 |
Why?
|
Thymus Gland | 1 | 1989 | 1266 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1989 | 12795 | 0.000 |
Why?
|
Genetic Variation | 1 | 1988 | 6613 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1989 | 26387 | 0.000 |
Why?
|